New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Biofrontera Inc.
BFRI
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

5M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

5M

Drug Manufacturers - Specialty & Generic

Next Earning date - 14 Nov 2024

0.91USD
Shape-0.06 ( -6.43%)
favorite-chart

Relative Strenght

47
favorite-chart

Volume Buzz

-88%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

83%

Quote Panel

Shape
Updated October 27, 2024
1W -3.72 % 1M -31.76 % 3M -26.21 % 1Y -76.12 %

Key Metrics

Shape
  • Market Cap

    5.03M


  • Shares Outstanding

    5.54M


  • Share in Float

    3.27M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    0.9076


  • Average Volume

    373560


  • Beta

    0.51


  • Range

    0.61-5.28


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.biofrontera.us.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.14x

P/S Ratio

0.42x

P/B Ratio

0.1

Debt/Equity

-38.4%

Net Margin

$-2.7

EPS

How BFRI compares to sector?

P/E Ratio

Relative Strength

Shape

BFRI

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$48M

Shape510%

2025-Revenue

$0.86

Shape-1603%

2025-EPS

$29M

Shape-505%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Benchmark

initialise

Previous: Not converted

2021-12-21

Now: Buy

Roth Capital

initialise

Previous: Not converted

2021-11-24

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-4.60
vs -10.20

Q4.22

arrow
arrow

N/A

-2.80
vs -25.89

Q1.23

arrow
arrow

N/A

-4.40
vs -1.60

Q2.23

arrow
arrow

N/A

-6.14
vs -8.80

Q3.23

arrow
arrow

N/A

-4.64
vs -4.60

Q4.23

arrow
arrow

N/A

-2.33
vs -2.80

Q1.24

arrow
arrow

N/A

-1.85
vs -4.40

Q2.24

arrow
arrow

N/A

-1.12
vs -6.14

Q3.24

arrow
arrow

N/A

-0.83
vs -4.64

Q4.24

arrow
arrow

N/A

-0.10
vs -2.33

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

0%

4.3M  vs 4.3M

Q4.22

arrow
arrow

+11%

10.1M  vs 9.2M

Q1.23

arrow
arrow

-10%

8.7M  vs 9.8M

Q2.23

arrow
arrow

+31%

5.8M  vs 4.5M

Q3.23

arrow
arrow

+105%

8.9M  vs 4.3M

Q4.23

arrow
arrow

+4%

10.6M  vs 10.1M

Q1.24

arrow
arrow

-10%

7.9M  vs 8.7M

Q2.24

arrow
arrow

+34%

7.8M  vs 5.8M

Q3.24

arrow
arrow

+13%

10M  vs 8.9M

Q4.24

arrow
arrow

+33%

14.1M  vs 10.6M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-11%

-0.11
vs 0.41

Q4.22

arrow
arrow

-12%

-0.12
vs -0.11

Q1.23

arrow
arrow

-45%

-0.45
vs -0.12

Q2.23

arrow
arrow

-137%

-1.37
vs -0.45

Q3.23

arrow
arrow

-611%

-6.11
vs -1.37

Q4.23

arrow
arrow

+74%

0.74
vs -6.11

Q1.24

arrow
arrow

+193%

1.93
vs 0.74

Q2.24

arrow
arrow

-2%

-0.02
vs 1.93

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

12

12
vs NA

NA

Q1.22

arrow
arrow

11

11
vs 12

-8%

Q2.22

arrow
arrow

13

13
vs 11

18%

Q3.22

arrow
arrow

13

13
vs 13

NA

Q4.22

arrow
arrow

14

14
vs 13

8%

Q1.23

arrow
arrow

15

15
vs 14

7%

Q2.23

arrow
arrow

11

11
vs 15

-27%

Q3.23

arrow
arrow

1

1
vs 11

-91%

Earnings Growth

Latest News